ECVT trades 18.1% above Wall Street's consensus target of $9.67.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ECVT achieves its forward estimates and maintains a stable P/E multiple of 17.8x. This scenario reflects the blended consensus of 6 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 7, 2026, Ecovyst Inc. (ECVT) has a Wall Street consensus price target of $9.67, based on estimates from 6 covering analysts. With the stock currently trading at $11.81, this represents a potential downside of -18.1%. The company has a market capitalization of $1.29B.
Analyst price targets range from a low of $9.00 to a high of $10.00, representing a 10% spread in expectations. The median target of $10.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 4 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ECVT trades at a trailing P/E of -19.4x and forward P/E of 17.8x. Analysts expect EPS to grow +217.3% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
ASIXAdvanSix Inc. | $542M | $20.10 | $22.00 | +9.5% | Buy | 14.0x | 6 |
IOSPInnospec Inc. | $2.0B | $82.41 | $115.00 | +39.5% | Hold | 17.2x | 9 |
TROXTronox Holdings plc | $962M | $6.03 | $8.33 | +38.1% | Buy | — | 17 |
KWRQuaker Chemical Corporation | $2.8B | $159.43 | $176.75 | +10.9% | Buy | 22.7x | 14 |
HWKNHawkins, Inc. | $2.9B | $139.44 | $170.00 | +21.9% | Buy | 35.4x | 1 |
CODICompass Diversified | $768M | $10.21 | $15.00 | +46.9% | Hold | 36.1x | 14 |
ALBAlbemarle Corporation | $15.8B | $133.80 | $209.75 | +56.8% | Hold | 10.8x | 45 |
MEOHMethanex Corporation | $3.4B | $43.82 | $68.80 | +57.0% | Buy | 4.9x | 19 |
PSXPhillips 66 | $71.1B | $177.33 | $181.11 | +2.1% | Buy | 9.9x | 35 |
VLOValero Energy Corporation | $80.8B | $270.32 | $257.38 | -4.8% | Buy | 9.3x | 37 |
Quick answers to the most common questions about buying ECVT stock.
ECVT's consensus price target is $9.67, -18.1% below the current price of $11.81. The 6 analysts tracking ECVT see downside risk at present valuations.
ECVT has a consensus rating of "Buy" based on 6 Wall Street analysts. The rating breakdown is predominantly bullish, with 4 Buy/Strong Buy ratings. The consensus 12-month price target of $9.67 implies -18.1% downside from current levels.
With a forward P/E of 17.8049x, ECVT trades at a relatively low valuation. The consensus target of $9.67 implies -18.1% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $10 for ECVT, while the most conservative target is $9. The consensus of $9.67 represents the median expectation. These targets typically reflect 12-month expectations.
ECVT is moderately covered, with 6 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ECVT stock forecast based on 6 Wall Street analysts shows a consensus price target of $9.67, with estimates ranging from $9 (bear case) to $10 (bull case). The median consensus rating is "Buy".
ECVT trades at a forward P/E ratio of 17.8x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on ECVT, with 0 Sell ratings and a price target of $9.67 (-18.1% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ECVT analyst price targets range from $9 to $10, a 10% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $9.67 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.